How best to treat agitation in patients with irreversible dementia?

dc.contributor.author	Beck, Stacie	eng
dc.contributor.author	Ludwig, Mary Jo	eng
dc.contributor.author	Safranek, Sarah	eng
dc.date.issued	2013	eng
dc.description.abstract	Atypical antipsychotics modestly reduce agitation compared with placebo but have significant adverse effects (strength of recommendation [SOR]: A, systematic reviews of randomized controlled trials [RCTs]). Haloperidol doesn't reduce symptoms and has serious adverse effects (SOR: A, systematic reviews of RCTs). Selective serotonin reuptake inhibitors (SSRIs) and melatonin--although well tolerated--don't reduce agitation (SOR: B, extrapolated data from systematic reviews of RCTs).	eng
dc.identifier.uri	http://hdl.handle.net/10355/36132	eng
dc.language	English	eng
dc.publisher	Family Physicians Inquiries Network	eng
dc.relation.ispartofcollection	Clinical Inquiries, 2013 (MU)	eng
dc.relation.ispartofcommunity	University of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network	eng
dc.relation.ispartofseries	Journal of family practice, 62, no. 07 (July 2013): 377+.	eng
dc.rights	OpenAccess.	eng
dc.rights.license	This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.	eng
dc.subject	antipsychotics	eng
dc.subject	agitation	eng
dc.subject	dementia	eng
dc.subject	symptom relief	eng
dc.subject.lcsh	Dementia -- Treatment	eng
dc.subject.lcsh	Agitation (Psychology)	eng
dc.title	How best to treat agitation in patients with irreversible dementia?	eng
dc.type	Article	eng

Clinical Inquiries, 2013
The items in this collection constitute volume 62 of Clinical Inquiries.